ESPERION THERAPEUTICS INC. - COMMON STOCK
2.0600
02-May-24 14:59:58
15 minutes delayed
Stocks
+0.0200
+0.98%
Today's range
2.0300 - 2.1200
ISIN
N/A
Source
NASDAQ
-
15 Jun 2023 13:30:00 By Nasdaq GlobeNewswire
-
08 Jun 2023 07:00:00 By Nasdaq GlobeNewswire
-
Esperion to Present Additional Analyses from the Landmark CLEAR Outcomes Study at ENDO 2023
05 Jun 2023 07:00:01 By Nasdaq GlobeNewswire
-
01 Jun 2023 07:00:01 By Nasdaq GlobeNewswire
-
Esperion Announces Adjournment of 2023 Annual Meeting of Stockholders
25 May 2023 15:30:00 By Nasdaq GlobeNewswire
-
Esperion to Participate in Jefferies Healthcare Conference
24 May 2023 07:00:01 By Nasdaq GlobeNewswire
-
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
12 May 2023 15:30:00 By Nasdaq GlobeNewswire
-
Esperion Reports First Quarter 2023 Financial Results
09 May 2023 06:00:02 By Nasdaq GlobeNewswire
-
04 May 2023 07:30:00 By Nasdaq GlobeNewswire
-
Esperion to Participate in JMP Securities Life Sciences Conference
01 May 2023 07:00:01 By Nasdaq GlobeNewswire
-
Esperion to Participate in Bank of America Securities 2023 Health Care Conference
27 Apr 2023 07:00:01 By Nasdaq GlobeNewswire
-
Esperion to Report First Quarter 2023 Financial Results May 9, 2023
25 Apr 2023 07:00:01 By Nasdaq GlobeNewswire
-
Esperion Announces Co-Promotion Agreement With Currax Pharmaceuticals LLC
19 Apr 2023 07:42:01 By Nasdaq GlobeNewswire
-
Esperion to Participate in Needham 22nd Annual Virtual Healthcare Conference
03 Apr 2023 07:00:00 By Nasdaq GlobeNewswire
-
22 Mar 2023 15:15:00 By Nasdaq GlobeNewswire
-
Esperion Announces $56.7 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
20 Mar 2023 07:00:00 By Nasdaq GlobeNewswire
-
08 Mar 2023 07:00:00 By Nasdaq GlobeNewswire
-
Esperion Launches New Scientific Website
24 Feb 2023 12:40:00 By Nasdaq GlobeNewswire
-
Esperion to Participate in the Cowen 43rd Annual Healthcare Conference
23 Feb 2023 07:00:02 By Nasdaq GlobeNewswire